A. Wieczorek
-
- Cancer, Lipids, and Metabolism 3
-
- Protein Kinase Regulation and GTPase Signaling 3
- RNA modifications and cancer 2
- Receptor Mechanisms and Signaling 2
- RNA Research and Splicing 2
-
- Lipoproteins and Cardiovascular Health 3
-
- Apelin-related biomedical research 2
-
- Adipose Tissue and Metabolism 2
- Cited by
- Cancer ResearchEndocrinology, Diabetes and MetabolismCardiology and Cardiovascular Medicine
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Biochemical and Biophysical Research Communications (1 paper)Atherosclerosis (2 papers)
- Partner nations
- GermanySwitzerlandPoland
In The Last Decade
A. Wieczorek
21 papers receiving 368 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 97
- Endocrinology, Diabetes and Metabolism 73
- Cardiology and Cardiovascular Medicine 93
- Molecular Biology 199
- Immunology and Allergy 13
Countries citing papers authored by A. Wieczorek
This map shows the geographic impact of A. Wieczorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wieczorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wieczorek more than expected).
Fields of papers citing papers by A. Wieczorek
This network shows the impact of papers produced by A. Wieczorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wieczorek. The network helps show where A. Wieczorek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Wieczorek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure]. | 1997 | 3 |
| 2 | Neuropsychopharmacological profile of remoxipride in comparison with clozapine. | 1997 | 9 |
| 3 | 1993 | 29 | |
| 4 | 1993 | 27 | |
| 5 | 1993 | 21 | |
| 6 | 1993 | 1 | |
| 7 | 1993 | 47 | |
| 8 | 1992 | 21 | |
| 9 | 1992 | 8 | |
| 10 | 1992 | 23 | |
| 11 | 1992 | 11 | |
| 12 | 1989 | 6 | |
| 13 | [Polycythemia vera: clinical aspects and course in 86 patients]. | 1988 | 6 |
| 14 | Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker. | 1987 | 38 |
| 15 | 1985 | 82 | |
| 16 | 1982 | 19 | |
| 17 | 1981 | 17 | |
| 18 | [Differentiation characteristics for the identification of patients with familial hypercholesteremia - studies on skin fibroblasts]. | 1978 | 1 |
| 19 | [Relationship between insulin binding and insulin effect in a special form of insulin resistance]. | 1978 | 1 |
| 20 | 1977 | 14 |
About A. Wieczorek
A. Wieczorek is a scholar working on Genetics, Physiology and Cancer Research, having authored 22 papers that have together received 395 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Apelin-related biomedical research (2 papers), Adipose Tissue and Metabolism (2 papers), RNA modifications and cancer (2 papers), Receptor Mechanisms and Signaling (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (97 citations), Endocrinology, Diabetes and Metabolism (73 citations) and Cardiology and Cardiovascular Medicine (93 citations). A. Wieczorek has collaborated with scholars based in Germany, Switzerland and Poland. Frequent co-authors include L H Block, Claudio Rhyner, Agapios Sachinidis, H. Vetter, Yon Ko, Y. Ko, F. A. Spengel, N. Zöllner, G Wolfram and V. Sitaramam. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.